433 related articles for article (PubMed ID: 28177894)
1. One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.
Shuvalov O; Petukhov A; Daks A; Fedorova O; Vasileva E; Barlev NA
Oncotarget; 2017 Apr; 8(14):23955-23977. PubMed ID: 28177894
[TBL] [Abstract][Full Text] [Related]
2. Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors.
Dang NH; Singla AK; Mackay EM; Jirik FR; Weljie AM
Curr Pharm Des; 2014; 20(15):2637-47. PubMed ID: 23859615
[TBL] [Abstract][Full Text] [Related]
3. One-carbon metabolism for cancer diagnostic and therapeutic approaches.
Asai A; Konno M; Koseki J; Taniguchi M; Vecchione A; Ishii H
Cancer Lett; 2020 Feb; 470():141-148. PubMed ID: 31759958
[TBL] [Abstract][Full Text] [Related]
4. Connections between metabolism and epigenetics in cancers.
Thakur C; Chen F
Semin Cancer Biol; 2019 Aug; 57():52-58. PubMed ID: 31185282
[TBL] [Abstract][Full Text] [Related]
5. A second Warburg-like effect in cancer metabolism: The metabolic shift of glutamine-derived nitrogen: A shift in glutamine-derived nitrogen metabolism from glutaminolysis to de novo nucleotide biosynthesis contributes to malignant evolution of cancer.
Kodama M; Nakayama KI
Bioessays; 2020 Dec; 42(12):e2000169. PubMed ID: 33165972
[TBL] [Abstract][Full Text] [Related]
6. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.
Dekhne AS; Hou Z; Gangjee A; Matherly LH
Mol Cancer Ther; 2020 Nov; 19(11):2245-2255. PubMed ID: 32879053
[TBL] [Abstract][Full Text] [Related]
8. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review).
Konno M; Asai A; Kawamoto K; Nishida N; Satoh T; Doki Y; Mori M; Ishii H
Int J Oncol; 2017 Apr; 50(4):1057-1063. PubMed ID: 28259896
[TBL] [Abstract][Full Text] [Related]
9. One-carbon metabolism in cancer.
Newman AC; Maddocks ODK
Br J Cancer; 2017 Jun; 116(12):1499-1504. PubMed ID: 28472819
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
11. Targeting one-carbon metabolism for cancer immunotherapy.
Ren X; Wang X; Zheng G; Wang S; Wang Q; Yuan M; Xu T; Xu J; Huang P; Ge M
Clin Transl Med; 2024 Jan; 14(1):e1521. PubMed ID: 38279895
[TBL] [Abstract][Full Text] [Related]
12. Glutamine Addiction and Therapeutic Strategies in Lung Cancer.
Vanhove K; Derveaux E; Graulus GJ; Mesotten L; Thomeer M; Noben JP; Guedens W; Adriaensens P
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634602
[TBL] [Abstract][Full Text] [Related]
13. Drugging cancer metabolism: Expectations vs. reality.
Montrose DC; Galluzzi L
Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the usage of the serine metabolic network in human cancer.
Mehrmohamadi M; Liu X; Shestov AA; Locasale JW
Cell Rep; 2014 Nov; 9(4):1507-19. PubMed ID: 25456139
[TBL] [Abstract][Full Text] [Related]
15. 'Rod and ring' formation from IMP dehydrogenase is regulated through the one-carbon metabolic pathway.
Calise SJ; Purich DL; Nguyen T; Saleem DA; Krueger C; Yin JD; Chan EK
J Cell Sci; 2016 Aug; 129(15):3042-52. PubMed ID: 27343244
[TBL] [Abstract][Full Text] [Related]
16. Target enzymes in serine-glycine-one-carbon metabolic pathway for cancer therapy.
Sun W; Zhao E; Cui H
Int J Cancer; 2023 Jun; 152(12):2446-2463. PubMed ID: 36346117
[TBL] [Abstract][Full Text] [Related]
17. Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.
Ononye SN; Shi W; Wali VB; Aktas B; Jiang T; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2014 Dec; 148(3):477-88. PubMed ID: 25395317
[TBL] [Abstract][Full Text] [Related]
18. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms of one-carbon metabolism enzymes.
Petrova B; Maynard AG; Wang P; Kanarek N
J Biol Chem; 2023 Dec; 299(12):105457. PubMed ID: 37949226
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
Gentric G; Mieulet V; Mechta-Grigoriou F
Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
